A PHASE 1B MULTIPLE ASCENDING DOSE STUDY TO ASSESS THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SZN-043, IN PARTICIPANTS WITH SEVERE ALCOHOL-ASSOCIATED HEPATITIS

Registry ID

CL-0043-1002

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

SURROZEN OPERATING, INC.

Start date

2024-08-12

Completion date

2025-04-14

Last update

2024-02-27

Conditions

• ALCOHOLIC HEPATITIS (AH)

Related clinical trials

• A PHASE 2, DOUBLE-BLIND, RANDOMIZED STUDY EVALUATING THE SAFETY, TOLERABILITY, AND EFFICACY OF GS-4997 IN COMBINATION WITH PREDNISOLONE VERSUS PREDNISOLONE ALONE IN SUBJECTS WITH SEVERE ALCOHOLIC HEPATITIS (AH)

View on source registry